The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Current role of melatonin in pediatric neurology: Clinical recommendations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ac09c9 · Cited by 637
Self-citationMelatonin in autism spectrum disorders: a systematic review and meta-analysis
ROSSIGNOL, D. A., & FRYE, R. E. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03980.x · Cited by 468 · cited 5×
“The majority of children with ASD responded to a dose of 1e3 mg given 30 min before bedtime, with improvement in sleep latency and total sleep duration.(67,69) The overall improvement rate with melatonin was 80%.”
BackgroundInfluentialBuscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., Vohra, S., Klassen, T. P., & Baker, G. (2006) · BMJ · doi:10.1136/bmj.38731.532766.f6 · Cited by 454
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378
Self-citationMelatonin treatment for age-related insomnia
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., & Leclair, O. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7901 · Cited by 308
Van der Heijden, K. B., Smits, M. G., Someren, E. J. W. V., & Boudewijn Gunning, W. (2005) · Chronobiology International · doi:10.1081/cbi-200062410 · Cited by 269
Self-citationHuman Phase Response Curves to Three Days of Daily Melatonin: 0.5 mg Versus 3.0 mg
Burgess, H. J., Revell, V. L., Molina, T. A., & Eastman, C. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2590 · Cited by 221
Owens, J. A., Rosen, C. L., & Mindell, J. A. (2003) · PEDIATRICS · doi:10.1542/peds.111.5.e628 · Cited by 214
A systematic review of two outcomes in autism spectrum disorder: epilepsy and mortality.
WOOLFENDEN, S., SARKOZY, V., RIDLEY, G., COORY, M., & WILLIAMS, K. (2012) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2012.04223.x · Cited by 206
Goldman, S. E., Adkins, K. W., Calcutt, M. W., Carter, M. D., Goodpaster, R. L., Wang, L., Shi, Y., Burgess, H. J., Hachey, D. L., & Malow, B. A. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2123-9 · Cited by 133
Research works printed but not linked: 106
- Gordon, 2000, The therapeutics of melatonin: a paediatric perspective, Brain Dev, 22, 213, 10.1016/S0387-7604(00)00120-0 · DOI
- Kennaway, 2000, Melatonin and development: physiology and pharmacology, Semin Perinatol, 24, 258, 10.1053/sper.2000.8594 · DOI
- Mauriz, 2013, A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives, J Pineal Res, 54, 1, 10.1111/j.1600-079X.2012.01014.x · DOI · Paper page
- Niles, 2004, Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers, BMC Neurosci, 5, 41, 10.1186/1471-2202-5-41 · DOI
- Iwasaki, 2005, Melatonin as a local regulator of human placental function, J Pineal Res, 39, 261, 10.1111/j.1600-079X.2005.00244.x · DOI
- Comai, 2013, Sleep–wake characterization of double MT(1)/MT(2) receptor knockout mice and comparison with MT(1) and MT(2) receptor knockout mice, Behav Brain Res, 243, 231, 10.1016/j.bbr.2013.01.008 · DOI
- Wirz-Justice, 1996, Melatonin: nature's soporific?, J Sleep Res, 5, 137, 10.1046/j.1365-2869.1996.d01-69.x · DOI
- Nagtegaal, 1998, Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset, J Sleep Res, 7, 135, 10.1046/j.1365-2869.1998.00102.x · DOI · Paper page
- van Geijlswijk, 2010, The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis, Sleep, 33, 1605, 10.1093/sleep/33.12.1605 · DOI · Paper page
- van Geijlswijk, 2010, Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT, Psychopharmacology, 212, 379, 10.1007/s00213-010-1962-0 · DOI
- Braam, 2010, Loss of response to melatonin treatment is associated with slow melatonin metabolism, J Intellect Disabil Res, 54, 547, 10.1111/j.1365-2788.2010.01283.x · DOI · Paper page
- Appleton, 2013, Melatonin: helping to MEND impaired sleep, Arch Dis Child, 98, 216, 10.1136/archdischild-2012-303606 · DOI
- Owens, 2009, Pharmacotherapy of pediatric insomnia, J Am Acad Child Adolesc Psychiatry, 48, 99, 10.1097/CHI.0b013e3181930639 · DOI
- Owens, 2010, Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey, Sleep Med, 11, 692, 10.1016/j.sleep.2009.11.015 · DOI · Paper page
- Hartz, 2012, Hypnotic drug use among 0–17 year olds during 2004–2011: a nationwide prescription database study, Scand J public health, 40, 704, 10.1177/1403494812464446 · DOI
- Heussler, 2013, Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian paediatric research network survey, Sleep Med, 14, 189, 10.1016/j.sleep.2012.09.023 · DOI
- Merchant, 2013, Pharmacokinetics of melatonin in preterm infants, Br J Clin Pharmacol, 76, 725, 10.1111/bcp.12092 · DOI
- Sadeh, 1997, Sleep and melatonin in infants: a preliminary study, Sleep, 20, 185
- LeBourgeois, 2013, Circadian phase and its relationship to nighttime sleep in toddlers, J Biol Rhythms, 28, 322, 10.1177/0748730413506543 · DOI
- Shinohara, 2011, Relationship between circadian salivary melatonin levels and sleep–wake behavior in infants, Pediatr Int off J Jpn Pediatr Soc, 53, 29, 10.1111/j.1442-200X.2010.03186.x · DOI
- Tauman, 2002, Melatonin production in infants, Pediatr Neurol, 26, 379, 10.1016/S0887-8994(01)00417-9 · DOI
- Hartmann, 1982, Plasma and urinary melatonin in male infants during the first 12 months of life, Clin Chimica Acta Int J Clin Chem, 121, 37, 10.1016/0009-8981(82)90208-X · doi:10.1016/0009-8981(82)90208-x
- Attanasio, 1986, Ontogeny of circadian rhythmicity for melatonin, serotonin, and N-acetylserotonin in humans, J Pineal Res, 3, 251, 10.1111/j.1600-079X.1986.tb00747.x · DOI
- Waldhauser, 1984, Fall in nocturnal serum melatonin during prepuberty and pubescence, Lancet, 1, 362, 10.1016/S0140-6736(84)90412-4 · DOI · Paper page
- Griefahn, 2003, Melatonin production during childhood and adolescence: a longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate, J Pineal Res, 34, 26, 10.1034/j.1600-079X.2003.02931.x · DOI
- Smits, 2003, Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial, J Am Acad Child Adolesc Psychiatry, 42, 1286, 10.1097/01.chi.0000085756.71002.86 · DOI · Paper page
- van Maanen, 2011, Termination of short term melatonin treatment in children with delayed dim light melatonin onset: effects on sleep, health, behavior problems, and parenting stress, Sleep Med, 12, 875, 10.1016/j.sleep.2011.03.019 · DOI
- Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J Pineal Res, 47, 1, 10.1111/j.1600-079X.2009.00681.x · DOI · Paper page
- van Geijlswijk, 2011, Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia, Psychopharmacology, 216, 111, 10.1007/s00213-011-2202-y · DOI
- EFSA, 2010, EFSA J, 8, 1467, 10.2903/j.efsa.2010.1467 · DOI
- EFSA, 2011, Panel on dietetic products NaAN. Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency (ID 1698, 1780, 4080) pursuant to article 13(1) of regulation (EC) no 1924/2006, EFSA J, 9, 2241, 10.2903/j.efsa.2011.2241 · DOI
- van der Heijden, 2005, Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia, J Sleep Res, 14, 187, 10.1111/j.1365-2869.2005.00451.x · DOI
- Keijzer, 2011, Evaluation of salivary melatonin measurements for dim light melatonin onset calculations in patients with possible sleep–wake rhythm disorders, Clin Chimica Acta Int J Clin Chem, 412, 1616, 10.1016/j.cca.2011.05.014 · DOI
- Keijzer, 2014, Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders, Sleep Med Rev, 18, 333, 10.1016/j.smrv.2013.12.001 · DOI
- Shibui, 1999, Melatonin rhythms in delayed sleep phase syndrome, J Biol Rhythms, 14, 72, 10.1177/074873099129000371 · DOI
- Ebisawa, 2001, Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome, EMBO Rep, 2, 342, 10.1093/embo-reports/kve070 · DOI · Paper page
- Archer, 2003, A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference, Sleep, 26, 413, 10.1093/sleep/26.4.413 · DOI · Paper page
- Gradisar, 2013, Delayed sleep phase disorder in youth, Curr Opin Psychiatry, 26, 580, 10.1097/YCO.0b013e328365a1d4 · DOI
- Micic, 2013, The endogenous circadian temperature period length (tau) in delayed sleep phase disorder compared to good sleepers, J Sleep Res, 22, 617, 10.1111/jsr.12072 · DOI · Paper page
- Buscemi, 2005, The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis, J Gen Intern Med, 20, 1151, 10.1111/j.1525-1497.2005.0243.x · DOI · Paper page
- Ferracioli-Oda, 2013, Meta-analysis: melatonin for the treatment of primary sleep disorders, PLoS One, 8, e63773, 10.1371/journal.pone.0063773 · DOI · Paper page
- Smits, 2001, Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial, J Child Neurol, 16, 86, 10.1177/088307380101600204 · DOI · Paper page
- Eckerberg, 2012, Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study, Chronobiol Int, 29, 1239, 10.3109/07420528.2012.719962 · DOI
- Wilhelmsen-Langeland, 2013, A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective and objective sleepiness and cognitive function, J Biological Rhythms, 28, 306, 10.1177/0748730413500126 · DOI
- Saxvig, 2014, A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: effects on subjective and objective sleep, Chronobiol Int, 31, 72, 10.3109/07420528.2013.823200 · DOI
- Braam, 2009, Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis, Dev Med Child Neurol, 51, 340, 10.1111/j.1469-8749.2008.03244.x · DOI
- Cortese, 2006, ADHD and insomnia, J Am Acad Child Adolesc Psychiatry, 45, 384, 10.1097/01.chi.0000199577.12145.bc · DOI
- Kirov, 2014, Sleep problems and their effect in ADHD, Expert Rev Neurother, 14, 287, 10.1586/14737175.2014.885382 · DOI
- Cortese, 2013, Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 52, 784, 10.1016/j.jaac.2013.06.001 · DOI · Paper page
- Owens, 2013, Future research directions in sleep and ADHD: report of a consensus working group, J Atten Disord, 17, 550, 10.1177/1087054712457992 · DOI · Paper page
- Weiss, 2006, Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia, J Am Acad Child Adolesc Psychiatry, 45, 512, 10.1097/01 chi.0000205706.78818.ef · DOI
- Mohammadi, 2012, Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial, Iran J psychiatry, 7, 87
- Krakowiak, 2008, Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study, J Sleep Res, 17, 197, 10.1111/j.1365-2869.2008.00650.x · DOI · Paper page
- Sivertsen, 2012, Sleep problems in children with autism spectrum problems: a longitudinal population-based study, Autism Int J Res Pract, 16, 139, 10.1177/1362361311404255 · DOI · Paper page
- Tordjman, 2005, Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder, Biol Psychiatry, 57, 134, 10.1016/j.biopsych.2004.11.003 · DOI · Paper page
- Veatch, 2014, Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay, J Autism Dev Disord
- Braam, 2013, CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder?, J Intellect Disabil Res, 57, 993, 10.1111/j.1365-2788.2012.01595.x · DOI
- Harrington, 2013, Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy, Autism Res off J Int Soc Autism Res, 6, 149, 10.1002/aur.1288 · DOI
- Daly, 2014, Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion, Brain, 137, 2600, 10.1093/brain/awu178 · DOI
- Sajith, 2007, Melatonin and sleep disorders associated with intellectual disability: a clinical review, J Intellect Disabil Res, 51, 2, 10.1111/j.1365-2788.2006.00893.x · DOI
- Gringras, 2012, Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial, BMJ, 345, e6664, 10.1136/bmj.e6664 · DOI · Paper page
- Hartter, 2001, Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study, Clin Pharmacol Ther, 70, 10, 10.1067/mcp.2001.116512 · DOI
- De Leersnyder, 2006, Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment, Trends Endocrinol Metab TEM, 17, 291, 10.1016/j.tem.2006.07.007 · DOI
- Chik, 2010, Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome, Am J Med Genet A, 152A, 96, 10.1002/ajmg.a.33158 · DOI
- Braam, 2008, Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial, J Child Neurol, 23, 649, 10.1177/0883073808314153 · DOI
- Bruni, 1995, Sleep disorders in tuberous sclerosis: a polysomnographic study, Brain Dev, 17, 52, 10.1016/0387-7604(94)00118-H · DOI
- O'Callaghan, 1999, Use of melatonin to treat sleep disorders in tuberous sclerosis, Dev Med Child Neurol, 41, 123, 10.1017/S0012162299000237 · DOI
- Hancock, 2005, Effect of melatonin dosage on sleep disorder in tuberous sclerosis complex, J Child Neurol, 20, 78, 10.1177/08830738050200011302 · doi:10.1177/08830738050200011302
- McArthur, 1998, Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment, Dev Med Child Neurol, 40, 186, 10.1111/j.1469-8749.1998.tb15445.x · DOI · Paper page
- De Leersnyder, 2011, Prolonged-release melatonin for children with neurodevelopmental disorders, Pediatr Neurol, 45, 23, 10.1016/j.pediatrneurol.2011.02.001 · DOI
- Fraser, 2002, Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians, Clin Genet, 62, 418, 10.1034/j.1399-0004.2002.620512.x · DOI
- Fraser, 2005, Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study, Arch Dis Child, 90, 1239, 10.1136/adc.2004.065482 · doi:10.1136/adc.2004.065482
- Goldberg-Stern, 2012, Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study, J Child Neurol, 27, 1524, 10.1177/0883073811435916 · DOI
- Brigo, 2012, Melatonin as add-on treatment for epilepsy, Cochrane Database Syst Rev, 6, CD006967
- Jain, 2013, Does melatonin affect epileptic seizures? Drug safety, Int J Med Toxicol drug Exp, 36, 207, 10.1007/s40264-013-0033-y · DOI
- Srinivasan, 2010, Potential use of melatonergic drugs in analgesia: mechanisms of action, Brain Res Bull, 81, 362, 10.1016/j.brainresbull.2009.12.001 · DOI
- Reiter, 2014, Melatonin: exceeding expectations, Physiology, 29, 325, 10.1152/physiol.00011.2014 · DOI · Paper page
- Wilhelmsen, 2011, Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies, J Pineal Res, 51, 270, 10.1111/j.1600-079X.2011.00895.x · DOI · Paper page
- Nagtegaal, 1998, Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations, Headache, 38, 303, 10.1046/j.1526-4610.1998.3804303.x · DOI
- Bruni, 1999, Sleep hygiene and migraine in children and adolescents. Cephalalgia, Int J headache, 19, 57, 10.1177/0333102499019S2516 · DOI · Paper page
- Rovers, 2014, Headache and sleep: also assess circadian rhythm sleep disorders, Headache, 54, 175, 10.1111/head.12217 · DOI
- Guidetti, 2014, The relationship between sleep and headache in children: implications for treatment, Cephalalgia Int J headache, 34, 767, 10.1177/0333102414541817 · DOI
- Miano, 2008, Melatonin to prevent migraine or tension-type headache in children, Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol, 29, 285
- Fallah, 2014, Safety and efficacy of melatonin in pediatric migraine prophylaxis, Curr drug Saf
- Lee, 2013, Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990, Pediatr Res, 74, 50, 10.1038/pr.2013.206 · DOI · Paper page
- Alonso-Alconada, 2013, Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia, Int J Mol Sci, 14, 9379, 10.3390/ijms14059379 · DOI
- Carloni, 2008, Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats, J Pineal Res, 44, 157, 10.1111/j.1600-079X.2007.00503.x · DOI · Paper page
- Alonso-Alconada, 2012, Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia, Histol Histopathol, 27, 771
- Robertson, 2013, Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model, Brain, 136, 90, 10.1093/brain/aws285 · DOI · Paper page
- Biran, 2014, Is melatonin ready to be used in preterm infants as a neuroprotectant?, Dev Med Child Neurol, 56, 717, 10.1111/dmcn.12415 · DOI
- Ramanantsoa, 2013, Bench to cribside: the path for developing a neuroprotectant, Transl stroke Res, 4, 258, 10.1007/s12975-012-0233-2 · DOI
- Eisermann, 2010, Melatonin: experience in its use for recording sleep EEG in children and review of the literature, Neuropediatrics, 41, 163, 10.1055/s-0030-1267920 · doi:10.1055/s-0030-1267920
- Ashrafi, 2010, Melatonin versus chloral hydrate for recording sleep EEG, Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc, 14, 235, 10.1016/j.ejpn.2009.06.010 · DOI
- Wassmer, 2001, Melatonin is useful for recording sleep EEGs: a prospective audit of outcome, Dev Med Child Neurol, 43, 735, 10.1017/S0012162201001347 · DOI
- Sander, 2012, Melatonin does not influence sleep deprivation electroencephalogram recordings in children, Eur J Pediatr, 171, 675, 10.1007/s00431-011-1640-1 · doi:10.1007/s00431-011-1640-1
- Espezel, 2000, Melatonin as a sedation substitute for diagnostic procedures, Dev Med Child Neurol, 42, 646, 10.1017/S0012162200221191 · doi:10.1017/s0012162200221191
- Schmidt, 2004, The use of melatonin as an alternative to sedation in children undergoing brainstem audiometry, Laryngo- Rhino- otologie, 83, 523, 10.1055/s-2004-814471 · doi:10.1055/s-2004-814471
- Wassmer, 2001, Melatonin as a sedation substitute for diagnostic procedures: MRI and EEG, Dev Med Child Neurol, 43, 136, 10.1017/S0012162201210251 · doi:10.1017/s0012162201210251
- Johnson, 2002, The use of melatonin as an alternative to sedation in uncooperative children undergoing an MRI examination, Clin Radiol, 57, 502, 10.1053/crad.2001.0923 · DOI
- Andersen, 2008, Melatonin for insomnia in children with autism spectrum disorders, J Child Neurol, 23, 482, 10.1177/0883073807309783 · DOI · Paper page
- Wasdell, 2008, A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities, J Pineal Res, 44, 57, 10.1111/j.1600-079X.2007.00528.x · DOI · Paper page
- Nagtegaal, 1996, Melatonin: a survey of suspected adverse drug reactions, Sleep–Wake Res Netherl, 7, 115
- Srinivasan, 2009, Melatonin and human reproduction: shedding light on the darkness hormone, Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol, 25, 779, 10.3109/09513590903159649 · DOI
- Carrillo-Vico, 2006, The modulatory role of melatonin on immune responsiveness, Curr Opin Investig Drugs, 7, 423
- Malow, 2012, Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes, J Autism Dev Disord, 42, 1729, 10.1007/s10803-011-1418-3 · DOI · Paper page
- Damiani, 2014, Melatonin: an option for managing sleep disorders in children with autism spectrum disorder, Am J Health-Syst Pharm AJHP Off J Am Soc Health-Sys Pharm, 71, 95, 10.2146/ajhp130215 · DOI
Cited by
Williams Buckley, A., Hirtz, D., Oskoui, M., Armstrong, M. J., Batra, A., Bridgemohan, C., Coury, D., Dawson, G., Donley, D., Findling, R. L., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009033 · Cited by 228
ADHD management during the COVID-19 pandemic: guidance from the European ADHD guidelines group
Cortese, S., Asherson, P., Sonuga-Barke, E., Banaschewski, T., Brandeis, D., Buitelaar, J., Coghill, D., Daley, D., Danckaerts, M., Dittmann, R. W., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30110-3 · Cited by 225
Self-citationMitochondrial and Cytoplasmic ROS Have Opposing Effects on Lifespan
Schaar, C. E., Dues, D. J., Spielbauer, K. K., Machiela, E., Cooper, J. F., Senchuk, M., Hekimi, S., & Van Raamsdonk, J. M. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004972 · Cited by 203
Mazzone, L., Postorino, V., Siracusano, M., Riccioni, A., & Curatolo, P. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7050102 · Cited by 172
Self-citationThe role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD?
Bijlenga, D., Vollebregt, M. A., Kooij, J. J. S., & Arns, M. (2019) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-018-0271-z · Cited by 137
Metadata
- Authors
- Bruni, O., Alonso-Alconada, D., Besag, F., Biran, V., Braam, W., Cortese, S., Moavero, R., Parisi, P., Smits, M., Van der Heijden, K., & Curatolo, P.
- Venue
- European Journal of Paediatric Neurology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 19
- Issue
- 2
- Pages
- 122-133
- ISSN
- 1090-3798 (ISSN-L)
- OpenAlex
- W1998574383
- Cited by
- 280
- References
- 14
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current role of melatonin in pediatric neurology: Clinical recommendations. https://app.cochat.ai/papers/10.1016/j.ejpn.2014.12.007
- The paper
- Bruni, O., Alonso-Alconada, D., Besag, F., Biran, V., Braam, W., Cortese, S., Moavero, R., Parisi, P., Smits, M., Van der Heijden, K., & Curatolo, P. (2015). Current role of melatonin in pediatric neurology: Clinical recommendations. European Journal of Paediatric Neurology. https://doi.org/10.1016/j.ejpn.2014.12.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.